Lessons from the dissection of the activation functions (AF-1 and AF-2) of the estrogen receptor alpha in vivo

Steroids

Volumn 78, Issue 6, 2013, Pages 576-582

  Arnal, Jean François ^a   Fontaine, Coralie ^a   Abot, Anne ^a   Valera, Marie Cécile ^a   Laurell, Henrik ^a   Gourdy, Pierre ^a   Lenfant, Françoise ^a  

^a Université de Toulouse   (France)

Author keywords

Estrogen; Estrogen receptor; Menopause; Uterus

Indexed keywords

AF 1 PROTEIN; AF 2 PROTEIN; DNA BINDING PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG;

BLEEDING TIME; CANCER CELL; CANCER GROWTH; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; ENDOMETRIUM CANCER; ESTROGEN ACTIVITY; ESTROGEN THERAPY; GENE INACTIVATION; GENE TARGETING; HEART; HORMONE SUBSTITUTION; HUMAN; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MENOPAUSE; NONHUMAN; RISK FACTOR; THROMBOCYTE FUNCTION; TRANSCRIPTION REGULATION; VEIN THROMBOSIS;

ANIMALS; ESTROGEN RECEPTOR ALPHA; HUMANS; MICE; RECEPTORS, GLUCOCORTICOID;

MAMMALIA;

EID: 84876665470     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.11.011     Document Type: Conference Paper

References (85)

1. P. Ascenzi, A. Bocedi, and M. Marino Structure-function relationship of estrogen receptor alpha and beta: impact on human health Mol Aspects Med 27 2006 299 402
2. J.W. Thornton, E. Need, and D. Crews Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling Science 301 2003 1714 1717
3. A. Krust, S. Green, P. Argos, V. Kumar, P. Walter, J.M. Bornert, and P. Chambon The chicken oestrogen receptor sequence. Homology with verba and the human oestrogen and glucocorticoid receptors EMBO J 5 1986 891 897
4. L. Tora, J. White, C. Brou, D. Tasset, N. Webster, E. Scheer, and P. Chambon The human estrogen receptor has two independent nonacidic transcriptional activation functions Cell 59 1989 477 487
5. N.J. McKenna, and B.W. O'Malley Combinatorial control of gene expression by nuclear receptors and coregulators Cell 108 2002 465 474
6. M. Nichols, J.M. Rientjes, and A.F. Stewart Different positioning of the ligand-binding domain helix 12 and the f domain of the estrogen receptor accounts for functional differences between agonists and antagonists EMBO J 17 1998 765 773
7. M.M. Montano, V. Muller, A. Trobaugh, and B.S. Katzenellenbogen The carboxy-terminal f domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists Mol Endocrinol 9 1995 814 825
8. A. Koide, C. Zhao, M. Naganuma, J. Abrams, S. Deighton-Collins, D.F. Skafar, and S. Koide Identification of regions within the f domain of the human estrogen receptor alpha that are important for modulating transactivation and protein-protein interactions Mol Endocrinol 21 2007 829 842
9. J.F. Couse, and K.S. Korach Estrogen receptor null mice. What have we learned and where will they lead us? Endocr Rev 20 1999 358 417
10. J.F. Arnal, F. Lenfant, G. Flouriot, F. Tremollieres, H. Laurell, C. Fontaine, and A. Krust From in vivo gene targeting of estrogen receptors to optimisation of their modulation in menopause Br J Pharmacol 165 2012 57 66
11. S.R. Hammes, and E.R. Levin Minireview: recent advances in extranuclear steroid receptor actions Endocrinology 152 2011 4489 4495
12. V.C. Jordan The past, present, and future of selective estrogen receptor modulation Ann N Y Acad Sci 949 2001 72 79
13. V.C. Jordan Tamoxifen: a most unlikely pioneering medicine Nat Rev Drug Discov 2 2003 205 213
14. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-1717.
15. J.E. Rossouw, R.L. Prentice, J.E. Manson, L. Wu, D. Barad, and V.M. Barnabei Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause JAMA 297 2007 1465 1477
16. J.C. Stevenson, H.N. Hodis, J.H. Pickar, and R.A. Lobo Coronary heart disease and menopause management: the swinging pendulum of HRT Atherosclerosis 207 2009 336 340
17. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial JAMA 288 2002 321 333
18. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, and H. Black Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women's health initiative randomized controlled trial JAMA 291 2004 1701 1712
19. G.L. Anderson, R.T. Chlebowski, J.E. Rossouw, R.J. Rodabough, A. McTiernan, and K.L. Margolis Prior hormone therapy and breast cancer risk in the women's health initiative randomized trial of estrogen plus progestin Maturitas 55 2006 103 115
20. C. Pequeux, I. Raymond-Letron, S. Blacher, F. Boudou, M. Adlanmerini, and M.J. Fouque Stromal ER-alpha promotes tumor growth by normalizing an increased angiogenesis Cancer Res 72 2012 3010 3019
21. R.H. Straub The complex role of estrogens in inflammation Endocr Rev 28 2007 521 574
22. C. Seillet, S. Laffont, F. Tremollieres, N. Rouquie, C. Ribot, and J.F. Arnal The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha-signaling Blood 119 2012 454 464
23. F. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, and B. Rosner Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453 461
24. T.B. Clarkson, and S.E. Appt Controversies about HRT-lessons from monkey models Maturitas 51 2005 64 74
25. P. Holm, H.L. Andersen, M.R. Andersen, E. Erhardtsen, and S. Stender The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits Circulation 100 1999 1727 1733
26. J.F. Arnal, P.Y. Scarabin, F. Tremollieres, H. Laurell, and P. Gourdy Estrogens in vascular biology and disease: where do we stand today? Curr Opin Lipidol 18 2007 554 560
27. K. Miyagawa, J. Rosch, F. Stanczyk, and K. Hermsmeyer Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm Nat Med 3 1997 324 327
28. E. Barrett-Connor Hormones and heart disease in women: the timing hypothesis Am J Epidemiol 166 2007 506 510
29. F. Lenfant, F. Tremollieres, P. Gourdy, and J.F. Arnal Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed? Maturitas 68 2011 165 173
30. D.M. Herrington, and K.P. Klein Invited review: pharmacogenetics of estrogen replacement therapy J Appl Physiol 91 2001 2776 2784
31. K.K. Koh, and B.K. Yoon Controversies regarding hormone therapy: insights from inflammation and hemostasis Cardiovasc Res 70 2006 22 30
32. E.R. Pomp, F.R. Rosendaal, and C.J. Doggen Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use Am J Hematol 83 2008 97 102
33. M. Canonico, E. Oger, G. Plu-Bureau, J. Conard, G. Meyer, and H. Levesque Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the esther study Circulation 115 2007 840 845
34. C. Renoux, S. Dell'aniello, E. Garbe, and S. Suissa Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study BMJ 340 2010 c2519
35. M.C. Valera, M.P. Gratacap, P. Gourdy, F. Lenfant, C. Cabou, and C.E. Toutain Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the haematopoietic estrogen receptor alpha Blood 2012
36. D.P. Edwards Regulation of signal transduction pathways by estrogen and progesterone Annu Rev Physiol 67 2005 335 376
37. R. Metivier, G. Penot, M.R. Hubner, G. Reid, H. Brand, and M. Kos Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter Cell 115 2003 751 763
38. M.T. Tzukerman, A. Esty, D. Santiso-Mere, P. Danielian, M.G. Parker, and R.B. Stein Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions Mol Endocrinol 8 1994 21 30
39. M. Berry, D. Metzger, and P. Chambon Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen EMBO J 9 1990 2811 2818
40. C.L. Smith, and B.W. O'Malley Coregulator function: a key to understanding tissue specificity of selective receptor modulators Endocr Rev 25 2004 45 71
41. D. Knutti, A. Kaul, and A. Kralli A tissue-specific coactivator of steroid receptors, identified in a functional genetic screen Mol Cell Biol 20 2000 2411 2422
42. H. Endoh, K. Maruyama, Y. Masuhiro, Y. Kobayashi, M. Goto, and H. Tai Purification and identification of p68 rna helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha Mol Cell Biol 19 1999 5363 5372
43. X. Wu, H. Li, and J.D. Chen The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor J Biol Chem 276 2001 23962 23968
44. Y. Kobayashi, T. Kitamoto, Y. Masuhiro, M. Watanabe, T. Kase, and D. Metzger P300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the n-terminal a/b domains J Biol Chem 275 2000 15645 15651
45. R. Metivier, G. Penot, G. Flouriot, and F. Pakdel Synergism between eralpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the n- and c-terminal domains Mol Endocrinol 15 2001 1953 1970
46. K.H. Kim, and J.R. Bender Membrane-initiated actions of estrogen on the endothelium Mol Cell Endocrinol 308 2009 3 8
47. E.R. Levin Integration of the extranuclear and nuclear actions of estrogen Mol Endocrinol 19 2005 1951 1959
48. S. Kousteni, T. Bellido, L.I. Plotkin, C.A. O'Brien, D.L. Bodenner, and L. Han Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity Cell 104 2001 719 730
49. M. Le Romancer, C. Poulard, P. Cohen, S. Sentis, J.M. Renoir, and L. Corbo Cracking the estrogen receptor's posttranslational code in breast tumors Endocr Rev 32 2011 597 622
50. M. Razandi, A. Pedram, S.T. Park, and E.R. Levin Proximal events in signaling by plasma membrane estrogen receptors J Biol Chem 278 2003 2701 2712
51. F. Acconcia, P. Ascenzi, A. Bocedi, E. Spisni, V. Tomasi, and A. Trentalance Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol Mol Biol Cell 16 2005 231 237
52. C.W. Wong, C. McNally, E. Nickbarg, B.S. Komm, and B.J. Cheskis Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade Proc Natl Acad Sci U S A 99 2002 14783 14788
53. Q. Lu, D.C. Pallas, H.K. Surks, W.E. Baur, M.E. Mendelsohn, and R.H. Karas Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial no synthase by estrogen receptor alpha Proc Natl Acad Sci U S A 101 2004 17126 17131
54. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1587
55. T. Simoncini Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging Climacteric 12 Suppl. 1 2009 6 11
56. D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach, and O. Smithies Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene Proc Natl Acad Sci U S A 90 1993 11162 11166
57. M.D. Iafrati, R.H. Karas, M. Aronovitz, S. Kim, T.R. Sullivan Jr., and D.B. Lubahn Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice Nat Med 3 1997 545 548
58. R.H. Karas, J.B. Hodgin, M. Kwoun, J.H. Krege, M. Aronovitz, and W. Mackey Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice Proc Natl Acad Sci U S A 96 1999 15133 15136
59. R.H. Karas, H. Schulten, G. Pare, M.J. Aronovitz, C. Ohlsson, and J.A. Gustafsson Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice Circ Res 89 2001 534 539
60. S. Dupont, A. Krust, A. Gansmuller, A. Dierich, P. Chambon, and M. Mark Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes Development 127 2000 4277 4291
61. L. Brouchet, A. Krust, S. Dupont, P. Chambon, F. Bayard, and J.F. Arnal Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta Circulation 103 2001 423 428
62. B. Darblade, C. Pendaries, A. Krust, S. Dupont, M.J. Fouque, and J. Rami Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor Circ Res 90 2002 413 419
63. G. Pare, A. Krust, R.H. Karas, S. Dupont, M. Aronovitz, and P. Chambon Estrogen receptor-alpha mediates the protective effects of estrogen against vascular injury Circ Res 90 2002 1087 1092
64. A. Billon-Gales, C. Fontaine, V. Douin-Echinard, L. Delpy, H. Berges, and B. Calippe Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice Circulation 120 2009 2567 2576
65. J.F. Couse, S.W. Curtis, T.F. Washburn, J. Lindzey, T.S. Golding, and D.B. Lubahn Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene Mol Endocrinol 9 1995 1441 1454
66. C. Pendaries, B. Darblade, P. Rochaix, A. Krust, P. Chambon, and K.S. Korach The AF-1 activation-function of eralpha may be dispensable to mediate the effect of estradiol on endothelial no production in mice Proc Natl Acad Sci U S A 99 2002 2205 2210
67. K.L. Chambliss, Q. Wu, S. Oltmann, E.S. Konaniah, M. Umetani, and K.S. Korach Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice J Clin Invest 120 2010 2319 2330
68. C. Bolego, A. Cignarella, P. Sanvito, V. Pelosi, F. Pellegatta, and L. Puglisi The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-alpha agonists and is abolished by estrogen deprivation J Pharmacol Exp Ther 313 2005 1203 1208
69. J.F. Arnal, C. Fontaine, A. Billon-Gales, J. Favre, and H. Laurell Estrogen receptors and endothelium Arterioscler Thromb Vasc Biol 30 2010 1506 1512
70. E.M. McInerney, and B.S. Katzenellenbogen Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation J Biol Chem 271 1996 24172 24178
71. D. Metzger, S. Ali, J.M. Bornert, and P. Chambon Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells J Biol Chem 270 1995 9535 9542
72. A. Billon-Gales, C. Fontaine, C. Filipe, V. Douin-Echinard, M.J. Fouque, and G. Flouriot The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17{beta}-estradiol Proc Natl Acad Sci U S A 106 2009 2053 2058
73. M. Kos, S. Denger, G. Reid, K.S. Korach, and F. Gannon Down but not out? A novel protein isoform of the estrogen receptor alpha is expressed in the estrogen receptor alpha knockout mouse J Mol Endocrinol 29 2002 281 286
74. A. Billon-Gales, A. Krust, C. Fontaine, A. Abot, G. Flouriot, and C. Toutain Activation function 2 (AF2) of estrogen receptor-{alpha} is required for the atheroprotective action of estradiol but not to accelerate endothelial healing Proc Natl Acad Sci U S A 108 2011 13311 13316
75. Y. Arao, K.J. Hamilton, M.K. Ray, G. Scott, Y. Mishina, and K.S. Korach Estrogen receptor alpha AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators Proc Natl Acad Sci U S A 108 2011 14986 14991
76. A.E. Borjesson, S.H. Windahl, M.K. Lagerquist, C. Engdahl, B. Frenkel, and S. Moverare-Skrtic Roles of transactivating functions 1 and 2 of estrogen receptor-{alpha} in bone Proc Natl Acad Sci U S A 108 2011 6288 6293
77. A. Pedram, M. Razandi, J.K. Kim, F. O'Mahony, E.Y. Lee, and U. Luderer Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse J Biol Chem 284 2009 3488 3495
78. P.A. Arias-Loza, V. Jazbutyte, and T. Pelzer Genetic and pharmacologic strategies to determine the function of estrogen receptor alpha and estrogen receptor beta in cardiovascular system Gend Med 5 Suppl. A 2008 S34 S45
79. C. Zhao, K. Dahlman-Wright, and J.A. Gustafsson Estrogen receptor beta: an overview and update Nucl Recept Signal 6 2008 e003
80. M.C. Antal, A. Krust, P. Chambon, and M. Mark Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant Proc Natl Acad Sci U S A 105 2008 2433 2438
81. R.J. Handa, S. Ogawa, J.M. Wang, and A.E. Herbison Roles for oestrogen receptor beta in adult brain function J Neuroendocrinol 24 2012 160 173
82. A. Pedram, M. Razandi, F. O'Mahony, D. Lubahn, and E.R. Levin Estrogen receptor-beta prevents cardiac fibrosis Mol Endocrinol 24 2010 2152 2165
83. A. Gougelet, S.O. Mueller, K.S. Korach, and J.M. Renoir Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ER alpha J Steroid Biochem Mol Biol 104 2007 110 122
84. T.H. Charn, E.T. Liu, E.C. Chang, Y.K. Lee, J.A. Katzenellenbogen, and B.S. Katzenellenbogen Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection Mol Endocrinol 24 2010 47 59
85. B.S. Katzenellenbogen, and J.A. Katzenellenbogen Biomedicine. Defining the "s" in serms Science 295 2002 2380 2381